BeFreed
    Categories>Well-Being>How Ramucirumab Works: Mechanism of Action and Key Differences

    How Ramucirumab Works: Mechanism of Action and Key Differences

    15 分钟
    |
    |
    2026年4月25日
    Well-BeingTechnologyEducation

    Explore how ramucirumab (Cyramza) works as a VEGFR2 antagonist. Learn about its unique mechanism of action in inhibiting angiogenesis and treating cancer.

    How Ramucirumab Works: Mechanism of Action and Key Differences

    How Ramucirumab Works: Mechanism of Action and Key Differences最佳语录

    “

    Ramucirumab heads straight for the lock itself—VEGFR-2—and sits right in it, acting as a surgical strike against the tumor's ability to feed itself by plugging the master lock on its infrastructure project.

    ”
    A

    Generated by Ahmed Obaid

    输入问题

    How ramucirumab works and why it's different

    主持声音
    Niaplay
    Eliplay
    知识来源
    Mechanism, Clinical Applications, and Biosimilars in Cancer Research
    link
    https://www.assaygenie.com/blog/ramucirumab-mechanism-clinical-applications-and-biosimilars-in-cancer-research/
    Targeted inhibition of VEGF Receptor-2: An update on Ramucirumab
    link
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4131847/
    OTT-80239-profile-of-ramucirumab-in-the-treatment-of-metastatic-non-sm
    link
    https://www.dovepress.com/getfile.php?fileID=29705
    link
    https://pi.lilly.com/us/cyramza-pi.pdf

    常见问题

    Ramucirumab, also known by the brand name Cyramza, is a fully human monoclonal antibody that functions as a VEGFR2 antagonist. It specifically binds to the Vascular Endothelial Growth Factor Receptor 2, blocking the binding of VEGF ligands. By preventing this interaction, the drug inhibits the signaling pathways that trigger the growth of new blood vessels, a process essential for tumor progression and survival.

    While many angiogenesis inhibitors target the VEGF ligands themselves, ramucirumab is different because it directly targets the VEGFR2 receptor. This specific mechanism of action allows it to block the activation of the receptor more directly than drugs that only neutralize circulating proteins. As a targeted monoclonal antibody, it provides a precise approach to disrupting the blood supply that tumors need to grow and spread.

    Ramucirumab is often discussed within the broader context of advanced cancer treatments and monoclonal antibodies. While its primary function is as an angiogenesis inhibitor rather than a traditional checkpoint inhibitor, it plays a critical role in modern oncology. By altering the tumor microenvironment and restricting blood vessel formation, it works alongside other therapies to improve outcomes for patients undergoing treatment for various types of solid tumors.

    由哥伦比亚大学校友创建 | 源自旧金山

    BeFreed 汇聚全球求知若渴的学习者

    4.7

    平均评分

    7,840+ 条 App 评分

    BeFreed 社区

    说真的,我还没把这个 app 完全摸透,但用了这几天已经被惊艳到了… BeFreed 和我用过的任何学习类 app 都不在一个层级。它让人特别投入,还能实实在在地提升专注力,对刷手机停不下来的人来说太合适了!

    @ladyInfinity

    我买 BeFreed 正好 23 天,从那以后每天都在用。它已经完全融入了我的日常工作流和学习习惯。

    @jayallen

    说实话,这个 app 超出了我所有的预期。我可以让它就任何主题生成音频,无论是什么,效果都很惊艳。我的专业领域是心理治疗方向,而且是多学科交叉的,但它给出的内容非常准确。

    @Raguipa

    我最感激的是它大大减少了我刷手机的时间——花在搜索上的时间少了,吸收信息的时间多了。完整有声书、播客加上学习计划的组合,真的很出色。

    @colonyofcreatorsNGO

    我做 PhotoReading 快速学习讲师已经 24 年了… 书籍、阅读和学习就是我的本行,而 BeFreed 用一种创新的方式,把知识变得特别容易吸收,做得非常出色。

    @BeFreed user

    它不只是一个书籍摘要 app。我用过「有趣」这个阅读模式,比传统方式的摘要好得多,理解观点也更容易,光这一点就值回票价。

    @austinakon

    我爱这个 app。用了几天,完全停不下来。作为开始,再好不过了。

    @jcrules328

    我真的很喜欢这个产品;已经试用了大概一个月,感觉挖到宝了。它特别好用,因为我可以用 BeFreed 创建自己想学的主题,声音也很棒,旁白选择多到用不完。

    @DanielCZ

    说真的,我还没把这个 app 完全摸透,但用了这几天已经被惊艳到了… BeFreed 和我用过的任何学习类 app 都不在一个层级。它让人特别投入,还能实实在在地提升专注力,对刷手机停不下来的人来说太合适了!

    @ladyInfinity

    我买 BeFreed 正好 23 天,从那以后每天都在用。它已经完全融入了我的日常工作流和学习习惯。

    @jayallen

    说实话,这个 app 超出了我所有的预期。我可以让它就任何主题生成音频,无论是什么,效果都很惊艳。我的专业领域是心理治疗方向,而且是多学科交叉的,但它给出的内容非常准确。

    @Raguipa

    我最感激的是它大大减少了我刷手机的时间——花在搜索上的时间少了,吸收信息的时间多了。完整有声书、播客加上学习计划的组合,真的很出色。

    @colonyofcreatorsNGO

    我做 PhotoReading 快速学习讲师已经 24 年了… 书籍、阅读和学习就是我的本行,而 BeFreed 用一种创新的方式,把知识变得特别容易吸收,做得非常出色。

    @BeFreed user

    它不只是一个书籍摘要 app。我用过「有趣」这个阅读模式,比传统方式的摘要好得多,理解观点也更容易,光这一点就值回票价。

    @austinakon

    我爱这个 app。用了几天,完全停不下来。作为开始,再好不过了。

    @jcrules328

    我真的很喜欢这个产品;已经试用了大概一个月,感觉挖到宝了。它特别好用,因为我可以用 BeFreed 创建自己想学的主题,声音也很棒,旁白选择多到用不完。

    @DanielCZ

    我特别喜欢它能把有用的信息和想法浓缩成 8-15 分钟的播客式音频。我本来不太爱听播客,因为废话太多,但它把这些全都去掉了。

    @BeFreed user

    我正在读博士的最后阶段,需要读大量不熟悉的材料… 用 BeFreed,只要输入一个提示,app 就会帮你找到源材料并生成一期音频播客。我觉得 BeFreed 的流程比 NotebookLM 更顺畅。

    @Brad

    我经常在做早餐、散步、通勤的时候上 YouTube 找点东西听,而 BeFreed 提供了更有针对性的选择,没有广告,也没有废话!

    @BeFreed user

    这个平台最棒的地方是它的多面性。真的没有任何主题是它讲不了的,你丢给它什么它都能处理… 很少能找到一个毫无限制、又真正兑现承诺的学习工具。

    @jayallen

    BeFreed 太棒了。界面好用,让我花在找功能上的时间更少,花在学习上的时间更多。有声书、播客和学习计划的组合是天才设计,彻底改变了我的日常。

    @BeFreed user

    一开始我花了点时间才弄明白怎么生成意大利语的播客,然后就——哇!太棒了!我可以让它讲解任何一个话题,它讲得又好又聪明!

    @matteo77

    BeFreed 已经成了我每天都用的有声书 app… 我最喜欢的是,把自己的文字放进去,它就能生成随时随地都能听的音频。

    @kotanzu1

    我特别喜欢它能把有用的信息和想法浓缩成 8-15 分钟的播客式音频。我本来不太爱听播客,因为废话太多,但它把这些全都去掉了。

    @BeFreed user

    我正在读博士的最后阶段,需要读大量不熟悉的材料… 用 BeFreed,只要输入一个提示,app 就会帮你找到源材料并生成一期音频播客。我觉得 BeFreed 的流程比 NotebookLM 更顺畅。

    @Brad

    我经常在做早餐、散步、通勤的时候上 YouTube 找点东西听,而 BeFreed 提供了更有针对性的选择,没有广告,也没有废话!

    @BeFreed user

    这个平台最棒的地方是它的多面性。真的没有任何主题是它讲不了的,你丢给它什么它都能处理… 很少能找到一个毫无限制、又真正兑现承诺的学习工具。

    @jayallen

    BeFreed 太棒了。界面好用,让我花在找功能上的时间更少,花在学习上的时间更多。有声书、播客和学习计划的组合是天才设计,彻底改变了我的日常。

    @BeFreed user

    一开始我花了点时间才弄明白怎么生成意大利语的播客,然后就——哇!太棒了!我可以让它讲解任何一个话题,它讲得又好又聪明!

    @matteo77

    BeFreed 已经成了我每天都用的有声书 app… 我最喜欢的是,把自己的文字放进去,它就能生成随时随地都能听的音频。

    @kotanzu1

    查看更多网络上关于 BeFreed 的讨论
    开启你的学习之旅,就是现在
    BeFreed 应用
    BeFreed

    个性化学习,无所不能

    DiscordLinkedIn
    精选书籍摘要
    Crucial ConversationsThe Perfect MarriageInto the WildNever Split the DifferenceAttachedGood to GreatSay Nothing
    热门分类
    Self HelpCommunication SkillRelationshipMindfulnessPhilosophyInspirationProductivity
    名人书单
    Elon MuskCharlie KirkBill GatesSteve JobsAndrew HubermanJoe RoganJordan Peterson
    获奖作品
    Pulitzer PrizeNational Book AwardGoodreads Choice AwardsNobel Prize in LiteratureNew York TimesCaldecott MedalNebula Award
    精选主题
    ManagementAmerican HistoryWarTradingStoicismAnxietySex
    年度最佳书籍
    2025 Best Non Fiction Books2024 Best Non Fiction Books2023 Best Non Fiction Books
    精选作者
    Chimamanda Ngozi AdichieGeorge OrwellO. J. SimpsonBarbara O'NeillWinston ChurchillCharlie Kirk
    BeFreed 与其他应用对比
    BeFreed vs. Other Book Summary AppsBeFreed vs. ElevenReaderBeFreed vs. ReadwiseBeFreed vs. Anki
    学习工具
    Knowledge VisualizerAI Podcast Generator
    更多信息
    关于我们arrow
    定价arrow
    常见问题arrow
    博客arrow
    招聘arrow
    合作伙伴arrow
    大使计划arrow
    目录arrow
    BeFreed
    Try now
    © 2026 BeFreed
    使用条款隐私政策
    BeFreed

    个性化学习,无所不能

    DiscordLinkedIn
    精选书籍摘要
    Crucial ConversationsThe Perfect MarriageInto the WildNever Split the DifferenceAttachedGood to GreatSay Nothing
    热门分类
    Self HelpCommunication SkillRelationshipMindfulnessPhilosophyInspirationProductivity
    名人书单
    Elon MuskCharlie KirkBill GatesSteve JobsAndrew HubermanJoe RoganJordan Peterson
    获奖作品
    Pulitzer PrizeNational Book AwardGoodreads Choice AwardsNobel Prize in LiteratureNew York TimesCaldecott MedalNebula Award
    精选主题
    ManagementAmerican HistoryWarTradingStoicismAnxietySex
    年度最佳书籍
    2025 Best Non Fiction Books2024 Best Non Fiction Books2023 Best Non Fiction Books
    学习工具
    Knowledge VisualizerAI Podcast Generator
    精选作者
    Chimamanda Ngozi AdichieGeorge OrwellO. J. SimpsonBarbara O'NeillWinston ChurchillCharlie Kirk
    BeFreed 与其他应用对比
    BeFreed vs. Other Book Summary AppsBeFreed vs. ElevenReaderBeFreed vs. ReadwiseBeFreed vs. Anki
    更多信息
    关于我们arrow
    定价arrow
    常见问题arrow
    博客arrow
    招聘arrow
    合作伙伴arrow
    大使计划arrow
    目录arrow
    BeFreed
    Try now
    © 2026 BeFreed
    使用条款隐私政策

    核心要点

    1

    The Infrastructure of a Shadow City

    0:00
    0:32
    1:02
    1:23
    1:43
    2

    The Master Lock and the Molecular Key

    1:54
    2:16
    2:21
    2:45
    2:59
    3:23
    3:34
    3

    Starving the Beast from the Inside Out

    3:57
    4:10
    4:34
    4:52
    5:16
    5:30
    5:52
    4

    Navigating the Side Effects of a Structural Shift

    6:11
    6:31
    6:39
    6:54
    6:58
    7:19
    7:38
    8:01
    5

    A Versatile Tool in the Oncology Toolkit

    8:18
    8:45
    8:55
    9:15
    9:27
    9:45
    9:55
    10:14
    6

    Beyond the Brand Name: The World of Biosimilars

    4:52
    10:48
    10:56
    11:17
    11:28
    11:43
    12:00
    7

    Your Guide to Understanding the Treatment Journey

    12:15
    12:33
    12:48
    13:05
    13:20
    13:37
    13:51
    8

    Reflections on a Molecular Blueprint for Hope

    14:02
    14:19
    14:34
    14:51
    6:58
    15:15

    相似内容

    Tagrisso vs Rybrevant: Is one extra year worth the risk? 书籍封面
    How to Read a PaperEmperor of All MaladiesSummary of Annette Bosworth's ANYWAY YOU CANEvery Patient Tells a Story
    24 sources
    Tagrisso vs Rybrevant: Is one extra year worth the risk?
    New MARIPOSA data shows a survival gap in EGFR lung cancer treatment. Learn how to weigh drug efficacy against side effects for better patient outcomes.
    28 min
    Erbitux vs Vectibix: Which EGFR Inhibitor Wins? 书籍封面
    Emperor of All MaladiesHow to Read a PaperElegant Defense : The Extraordinary New Science of the Immune SystemThe Immortal Life of Henrietta Lacks
    23 sources
    Erbitux vs Vectibix: Which EGFR Inhibitor Wins?
    Choosing between cetuximab and panitumumab is tricky. We break down new JSCCR data on survival rates and molecular differences to help you decide.
    28 min
    Starving Cancer: The Insulin and Sugar Connection 书籍封面
    Sugar and Cancer | UCSF Osher Center for Integrative HealthUncovering the Links Between Dietary Sugar and Cancer: A Narrative Review Exploring the Impact of Dietary Sugar and Fasting on Cancer Risk and Prevention - PMCMetabolism | CancerQuestInsulin growth factor (IGF-1)
    6 sources
    Starving Cancer: The Insulin and Sugar Connection
    Cancer cells are addicted to glucose, but cutting sugar is about more than just fuel. Learn how insulin and inflammation drive tumor growth.
    1217 min
    Leucovorin and 5-FU: Why It Isn't a Rescue Agent 书籍封面
    Summary of Annette Bosworth's ANYWAY YOU CANEmperor of All MaladiesHow Not to DieHow to Read a Paper
    22 sources
    Leucovorin and 5-FU: Why It Isn't a Rescue Agent
    Why does leucovorin boost 5-FU toxicity instead of preventing it? Learn how this biochemical potentiator stabilizes the ternary complex to treat cancer.
    33 min
    Bloodstream Brain Implants Revolutionize Neuromedicine 书籍封面
    The Patient Will See You NowLife ForceEnding AgingDo No Harm
    18 sources
    Bloodstream Brain Implants Revolutionize Neuromedicine
    Discover how 'Circulatronics' delivers tiny wireless devices through the bloodstream to treat neurological conditions without invasive surgery, using immune cells as natural carriers to target inflammation.
    35 min
    How Berberine Targets the Metabolic Roots of Disease 书籍封面
    Direct source: pubmed.ncbi.nlm.nih.gov
    1 source
    How Berberine Targets the Metabolic Roots of Disease
    Cancer and arthritis share a hidden metabolic fuel. Learn how berberine targets specific proteins to stop disease growth while sparing healthy cells.
    33 min
    Rosiver and the Mite Connection 书籍封面
    Regulatory Decision Summary for Rosiver - Drug and Health Products Portal[Product Monograph Template - Standard]Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with RosaceaTopical Ivermectin: Data Supporting Dual Modes of Action in Rosacea
    6 sources
    Rosiver and the Mite Connection
    Struggling with stubborn rosacea flare-ups? Learn how targeting skin mites with ivermectin cream can calm inflammation and provide long-term relief.
    15 min
    Brukinsa vs Calquence: Why the Single Drug May Win 书籍封面
    Emperor of All MaladiesElegant Defense : The Extraordinary New Science of the Immune SystemEvery Patient Tells a StoryEvery Patient Tells a Story
    21 sources
    Brukinsa vs Calquence: Why the Single Drug May Win
    Choosing between CLL treatments is getting harder. We compare recent data on Brukinsa and Calquence to see which BTK inhibitor offers better survival.
    13 min